Logo
x

Search

Subscribe Now

ATLAS

ViiV Healthcare Present Results of Long-Acting Cabotegravir and Rilpivirine at IDWeeK 2020

ViiV Healthcare Present Results of Long-Acting Cabotegravir and Rilpivirine at IDWeeK 2020

  • October 22, 2020
Janssen (J&J) Reports Positive Results of Rilpivirine + Cabotegravir in P-III ATLAS and FLAIR Studies for HIV

Janssen (J&J) Reports Positive Results of Rilpivirine + Cabotegravir in P-III ATLAS and FLAIR Studies for HIV

  • March 8, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.